NCT04863261

Cabenuva Injection Tracking in CHORUS

Facilitating the Management of CAB+RPV LA Patient Visits Through Daily Alerts and Morning Huddles

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: Epividian · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This is a cluster randomized trial in which clinics will be randomized to the intervention or the control arm. The purpose of this study is to assess if receiving alerts can help providers manage the scheduling of monthly cabotegravir + rilpivirine long-acting injections for the treatment of HIV.

Detailed description

A novel long-acting HIV antiretroviral therapy has recently been approved by the FDA: cabotegravir and rilpivirine delivered through intramuscular injection. These injections should be administered monthly, on the same day of the month as the initiation injections, up to 7 days before or after the date of the scheduled monthly injection visit. This is a cluster randomized trial in which clinics will be randomized to the intervention or the control arm. Providers in the intervention group will receive alerts to remind them when patients are due for their injections, or if they missed their treatment window. Providers in the control group will not receive alerts and will manage injections as per their clinic's standard process. Surveys will be administered to understand the utility of the alerts for the management of these injections.

Conditions

• HIV Infections

Interventions

Type	Name	Description
OTHER	Cabenuva Scheduling Alerts in the Retention & Huddle modules of the CHORUS App	The CHORUS App has been developed as a tool for clinicians to easily visualize important patient information from their smart phones. Relevant information is electronically distributed and placed within the corresponding module in the CHORUS HCP mobile app for iOS and Android.

Timeline

• Start date: 2021-10-01
• Primary completion: 2022-07-07
• Completion: 2022-07-07
• First posted: 2021-04-28
• Last updated: 2025-02-25

Locations

1 site across 1 country: United States